Zitagluc Plus FC Tablets
PDF Leaflet Revision Date: 08 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to diet and exercise for type 2 diabetes control.
Dosage (summary)
50 mg sitagliptin/500 mg metformin, twice daily with meals.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Alcohol
- Iodinated contrast media
- Sulphonylureas
Contraindications
- Renal disease
- Hypersensitivity to components
- Acute metabolic acidosis
- Hepatic impairment
- Breastfeeding
Common side effects
- Nausea
- Diarrhea
- Hypoglycemia
- Somnolence
Counselling Points
- Monitor blood glucose regularly.
- Avoid excessive alcohol intake.
- Report symptoms of pancreatitis.
Serious warnings
- Risk of lactic acidosis
- Serious hypersensitivity reactions
- Pancreatitis
Important Disclaimer
The Zitagluc Plus FC Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
